The average duration of ADT was 40.63 (SD 24.71) months, the mean prostate-specific antigen level was 0.07 (SD 0.19) ng/ml, and the mean Gleason score, which determines the prognosis and pathological status of cancer, was 7.80 (SD 0.98). This evidence concerns the gene KLK3 and cancer.